Ansun Biopharma Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$100M
- Investors
-
15
Ansun Biopharma General Information
Description
Operator of a clinical-stage biopharmaceutical company intended to develop therapies that prevent, treat, and cure vexing human diseases. The company's therapy utilizes a host-directed anti-viral biological product that aims to treat respiratory viral infections such as influenza virus, para influenza virus, and metapneumovirus, enabling medical practitioners to treat and cure life-threatening human diseases.
Contact Information
Website
www.ansunbiopharma.comCorporate Office
- 10045 Mesa Rim Road
- Suite 12
- San Diego, CA 92121
- United States
Corporate Office
- 10045 Mesa Rim Road
- Suite 12
- San Diego, CA 92121
- United States
Ansun Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 18-Nov-2020 | $100M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series A) | 14-May-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 22-Dec-2015 | Completed | Generating Revenue | |||
| 5. Seed Round | 22-May-2014 | Completed | Clinical Trials - Phase 3 | |||
| 4. Seed Round | 29-May-2013 | Completed | Clinical Trials - Phase 3 | |||
| 3. Seed Round | 10-Nov-2011 | Completed | Clinical Trials - Phase 3 | |||
| 2. Grant | 01-Jan-2010 | $3.84M | Completed | Clinical Trials - Phase 1 | ||
| 1. Grant | 01-Jan-2005 | $6M | Completed | Clinical Trials - Phase 2 |
Ansun Biopharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 47,543,582 | $0.000010 | $1.26 | $1.26 | 1x | $1.26 | 14.13% |
Ansun Biopharma Comparisons
Industry
Financing
Details
Ansun Biopharma Competitors (32)
One of Ansun Biopharma’s 32 competitors is Moerae Matrix, a Formerly VC-backed company based in Morristown, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Moerae Matrix | Formerly VC-backed | Morristown, NJ | ||||
| hVIVO | Formerly VC-backed | London, United Kingdom | ||||
| Vasa Therapeutics | Venture Capital-Backed | Encinitas, CA | ||||
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom | ||||
| Aqualung Therapeutics | Venture Capital-Backed | Tucson, AZ |
Ansun Biopharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ansun Biopharma Patents
Ansun Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022380713-A1 | Das181 variant compositions | Pending | 02-Nov-2021 | ||
| EP-4426335-A1 | Das181 variant compositions | Pending | 02-Nov-2021 | ||
| CA-3237027-A1 | Das181 variant compositions | Pending | 02-Nov-2021 | ||
| JP-2024540218-A | Das181 variant compositions | Pending | 02-Nov-2021 | ||
| EP-4093416-A1 | Delivery of sialidase to cancer cells, immune cells and the tumor microenvironment | Inactive | 21-Jan-2020 | C12N15/86 |
Ansun Biopharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ansun Biopharma Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China International Capital Corporation | Investment Bank | Minority | ||
| Greater Bay Area Homeland | Venture Capital | Minority | ||
| Junson Capital | Asset Manager | Minority | ||
| Korea Investment Partners | Venture Capital | Minority | ||
| 3E Bioventures (China) | Venture Capital | Minority |
Ansun Biopharma FAQs
-
When was Ansun Biopharma founded?
Ansun Biopharma was founded in 2003.
-
Where is Ansun Biopharma headquartered?
Ansun Biopharma is headquartered in San Diego, CA.
-
What is the size of Ansun Biopharma?
Ansun Biopharma has 27 total employees.
-
What industry is Ansun Biopharma in?
Ansun Biopharma’s primary industry is Drug Discovery.
-
Is Ansun Biopharma a private or public company?
Ansun Biopharma is a Private company.
-
What is the current valuation of Ansun Biopharma?
The current valuation of Ansun Biopharma is .
-
What is Ansun Biopharma’s current revenue?
The current revenue for Ansun Biopharma is .
-
How much funding has Ansun Biopharma raised over time?
Ansun Biopharma has raised $211M.
-
Who are Ansun Biopharma’s investors?
China International Capital Corporation, Greater Bay Area Homeland, Junson Capital, Korea Investment Partners, and 3E Bioventures (China) are 5 of 15 investors who have invested in Ansun Biopharma.
-
Who are Ansun Biopharma’s competitors?
Moerae Matrix, hVIVO, Vasa Therapeutics, Enterprise Therapeutics, and Aqualung Therapeutics are some of the 32 competitors of Ansun Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
